GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Sep 16, 2025, 12:46 PM EDT
GB Sciences Market Cap
GB Sciences has a market cap or net worth of $81.41 thousand as of September 16, 2025. Its market cap has decreased by -97.23% in one year.
Market Cap
81.41K
Enterprise Value
2.07M
Revenue
97.24K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 19, 2014, GB Sciences's market cap has decreased from 2.53M to 81.41K, a decrease of -96.79%. That is a compound annual growth rate of -25.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 81.41K | -95.00% |
| Dec 31, 2024 | 1.63M | -36.83% |
| Dec 29, 2023 | 2.58M | -61.28% |
| Dec 30, 2022 | 6.66M | 2.29% |
| Dec 31, 2021 | 6.51M | -44.95% |
| Dec 31, 2020 | 11.82M | 12.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |